Financial Management Professionals Inc. Cuts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Financial Management Professionals Inc. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 31.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 164 shares of the company’s stock after selling 74 shares during the period. Financial Management Professionals Inc.’s holdings in HCA Healthcare were worth $49,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Benjamin F. Edwards & Company Inc. bought a new position in HCA Healthcare during the second quarter valued at $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Canoe Financial LP purchased a new stake in HCA Healthcare during the third quarter valued at approximately $41,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $41,000. Finally, Northwest Investment Counselors LLC bought a new stake in HCA Healthcare in the third quarter worth $44,000. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Up 0.4 %

NYSE HCA opened at $310.60 on Monday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 12 month low of $278.50 and a 12 month high of $417.14. The company has a market capitalization of $78.68 billion, a price-to-earnings ratio of 13.95, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64. The firm’s fifty day moving average price is $316.69 and its 200 day moving average price is $353.01.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s payout ratio is currently 11.85%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.